Follow
Cecilia Jazmín Proietti
Cecilia Jazmín Proietti
PhD, Associate Investigator, Institute of Biology & Experimental Medicine
Verified email at ibyme.conicet.gov.ar
Title
Cited by
Cited by
Year
TNFα acting on TNFR1 promotes breast cancer growth via p42/P44 MAPK, JNK, Akt and NF-κB-dependent pathways
MA Rivas, RP Carnevale, CJ Proietti, C Rosemblit, W Beguelin, ...
Experimental cell research 314 (3), 509-529, 2008
2042008
Progestins induce transcriptional activation of signal transducer and activator of transcription 3 (Stat3) via a Jak-and Src-dependent mechanism in breast cancer cells
C Proietti, M Salatino, C Rosemblit, R Carnevale, A Pecci, AR Kornblihtt, ...
Molecular and cellular biology 25 (12), 4826-4840, 2005
1692005
Progestin Effects on Breast Cancer Cell Proliferation, Proteases Activation, and in Vivo Development of Metastatic Phenotype All Depend on Progesterone …
RP Carnevale, CJ Proietti, M Salatino, A Urtreger, G Peluffo, DP Edwards, ...
Molecular endocrinology 21 (6), 1335-1358, 2007
1262007
Progesterone receptor induces ErbB-2 nuclear translocation to promote breast cancer growth via a novel transcriptional effect: ErbB-2 function as a coactivator of Stat3
W Béguelin, MCD Flaqué, CJ Proietti, F Cayrol, MA Rivas, M Tkach, ...
Molecular and cellular biology 30 (23), 5456-5472, 2010
1162010
Heregulin induces transcriptional activation of the progesterone receptor by a mechanism that requires functional ErbB-2 and mitogen-activated protein kinase activation in …
L Labriola, M Salatino, CJ Proietti, A Pecci, OA Coso, AR Kornblihtt, ...
Molecular and cellular biology 23 (3), 1095-1111, 2003
1112003
TNFα-Induced Mucin 4 Expression Elicits Trastuzumab Resistance in HER2-Positive Breast Cancer
MF Mercogliano, M De Martino, L Venturutti, MA Rivas, CJ Proietti, ...
Clinical Cancer Research 23 (3), 636-648, 2017
1042017
p42/p44 MAPK-mediated Stat3Ser727 phosphorylation is required for progestin-induced full activation of Stat3 and breast cancer growth
M Tkach, C Rosemblit, MA Rivas, CJ Proietti, MCD Flaqué, ...
Endocrine-related cancer 20 (2), 197-212, 2013
992013
Tamoxifen resistance in breast cancer is regulated by the EZH2-ERα-GREB1 transcriptional axis
Y Wu, Z Zhang, ME Cenciarini, CJ Proietti, MF Amasino, T Hong, M Yang, ...
Cancer research, canres. 1327.2017, 2017
932017
Inhibition of in vivo breast cancer growth by antisense oligodeoxynucleotides to type I insulin-like growth factor receptor mRNA involves inactivation of ErbBs, PI-3K/Akt and …
M Salatino, R Schillaci, CJ Proietti, R Carnevale, I Frahm, AA Molinolo, ...
Oncogene 23 (30), 5161-5174, 2004
872004
MiR-16 mediates trastuzumab and lapatinib response in ErbB-2-positive breast and gastric cancer via its novel targets CCNJ and FUBP1
L Venturutti, RIC Russo, MA Rivas, MF Mercogliano, F Izzo, RH Oakley, ...
Oncogene 35 (48), 6189-6202, 2016
822016
Stat3 regulates ErbB-2 expression and co-opts ErbB-2 nuclear function to induce miR-21 expression, PDCD4 downregulation and breast cancer metastasis
L Venturutti, LV Romero, AJ Urtreger, MF Chervo, RIC Russo, ...
Oncogene 35 (17), 2208-2222, 2016
752016
Activation of Stat3 by heregulin/ErbB-2 through the co-option of progesterone receptor signaling drives breast cancer growth
CJ Proietti, C Rosemblit, W Beguelin, MA Rivas, MCD Flaqué, ...
Molecular and cellular biology 29 (5), 1249-1265, 2009
712009
Activation of Stat3 by heregulin/ErbB-2 through the co-option of progesterone receptor signaling drives breast cancer growth
CJ Proietti Anastasi, C Rosemblit, W Beguelin, MA Rivas, MC Díaz Flaqué, ...
American Society for Microbiology, 2009
71*2009
Targeting ErbB-2 nuclear localization and function inhibits breast cancer growth and overcomes trastuzumab resistance
RIC Russo, W Béguelin, MCD Flaqué, CJ Proietti, L Venturutti, ...
Oncogene 34 (26), 3413-3428, 2015
612015
Progestin-induced caveolin-1 expression mediates breast cancer cell proliferation
M Salatino, W Beguelin, MG Peters, R Carnevale, CJ Proietti, ...
Oncogene 25 (59), 7723-7739, 2006
602006
Targeting Stat3 induces senescence in tumor cells and elicits prophylactic and therapeutic immune responses against breast cancer growth mediated by NK cells and CD4+ T cells
M Tkach, L Coria, C Rosemblit, MA Rivas, CJ Proietti, MCD Flaqué, ...
The Journal of Immunology 189 (3), 1162-1172, 2012
552012
Progesterone receptor assembly of a transcriptional complex along with activator protein 1, signal transducer and activator of transcription 3 and ErbB-2 governs breast cancer …
MCD Flaqué, NM Galigniana, W Béguelin, R Vicario, CJ Proietti, ...
Breast Cancer Research 15 (6), R118, 2013
452013
Clinical relevance of ErbB-2/HER2 nuclear expression in breast cancer
R Schillaci, P Guzmán, F Cayrol, W Beguelin, MCD Flaqué, CJ Proietti, ...
BMC cancer 12 (1), 74, 2012
452012
Transactivation of ErbB-2 induced by tumor necrosis factor α promotes NF-κB activation and breast cancer cell proliferation
MA Rivas, M Tkach, W Beguelin, CJ Proietti, C Rosemblit, EH Charreau, ...
Breast cancer research and treatment 122 (1), 111-124, 2010
452010
Immunization with murine breast cancer cells treated with antisense oligodeoxynucleotides to type I insulin-like growth factor receptor induced an antitumoral effect mediated …
R Schillaci, M Salatino, J Cassataro, CJ Proietti, GH Giambartolomei, ...
The Journal of Immunology 176 (6), 3426-3437, 2006
452006
The system can't perform the operation now. Try again later.
Articles 1–20